Comments
Aurobindo Pharma Ltd posted consolidated net loss of Rs 123 crore in the first quarter ended June 30, 2011.
The Hyderabad-based company earned net profit of Rs 51.5 crore profit in the corresponding quarter of previous year.
The total revenue, however, had increased to Rs 1100 crore (Rs 943 crore) driven by 26 per cent increase in formulation sales, among others. The loss per share was at Rs 4.20.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.